Quantification of hepatic steatosis: A comparison of computed tomography and magnetic resonance indices in candidates for living liver donation

Academic Radiology

Volumn 21, Issue 4, 2014, Pages 507-513

  Maruzzelli, Luigi ^a   Parr, Anthony J ^b   Miraglia, Roberto ^a   Tuzzolino, Fabio ^a   Luca, Angelo ^a  

^a MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Computed tomography; Liver; Magnetic resonance; Steatosis; Transplant

Indexed keywords

ADULT; ARTICLE; ATTENUATION; BODY MASS; COMPARATIVE STUDY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER SYSTEM; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FATTY LIVER; FEMALE; HUMAN; LIVER BIOPSY; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ORGAN DONOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPLEEN; YOUNG ADULT;

BIOPSY; COMPUTED TOMOGRAPHY; LIVER; MAGNETIC RESONANCE; STEATOSIS; TRANSPLANT;

ADOLESCENT; ADULT; FATTY LIVER; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER TRANSPLANTATION; LIVING DONORS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; PREOPERATIVE CARE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84896862108     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2014.01.007     Document Type: Article

References (32)

1. Fan S.T., Lo C.M., Liu C.L., et al. Safety of donors in live donor liver transplantation using right lobe grafts. Arch Surg 2000, 135:336-340.
2. Brancatelli G. Science to practice: should biopsy be performed in potential live donors when unenhanced CT shows an unacceptable degree of steatosis for transplantation?. Radiology 2006, 239:1-2.
3. Limanond P., Raman S.S., Lassman C., et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 2004, 230:276-280.
4. Park S.H., Kim P.N., Kim K.W., et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006, 239:105-112.
5. Rinella M.E., McCarthy R., Thakrar K., et al. Dual-echo, chemical shift gradient-echo magnetic resonance imaging to quantify hepatic steatosis: implications for living liver donation. Liver Transplant 2003, 9:851-856.
6. Kim S.H., Lee J.M., Han J.K., et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging-correlation with histopathologic findings. Radiology 2006, 240:116-129.
7. Yamashiki N., Sugawara Y., Tamura S., et al. Noninvasive estimation of hepatic steatosis in living liver donors: usefulness of visceral fat area measurement. Transplantation 2009, 88:575-581.
8. Kim D.Y., Park S.H., Lee S.S., et al. Contrast-enhanced computed tomography for the diagnosis of fatty liver: prospective study with same-day biopsy used as the reference standard. Eur Radiol 2010, 20:359-366.
9. Yoshimitsu K., Kuroda Y., Nakamuta M., et al. Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging 2008, 28:678-684.
10. Lee S.S., Park S.H., Kim H.J., et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J Hepatol 2010, 52:579-585.
11. Qayyum A., Goh J.S., Kakar S., et al. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fastspin-echo techniques-initial experience. Radiology 2005, 237:507-511.
12. Minervini M.I., Ruppert K., Fontes P., et al. Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J Hepatol 2009, 50:501-510.
13. Ma X., Holalkere N.S., Kambadakone R.A., et al. Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 2009, 29:1253-1277.
14. McPherson S., Jonsson J.R., Cowin G.J., et al. Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered. J Hepatol 2009, 51:389-397.
15. DeLong E.R., DeLong D.M., Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44:837-845.
16. Saadeh S., Younossi Z.M., Remer E.M., et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-750.
17. Cho C.S., Curran S., Schwartz L.H., et al. Preoperative radiographic assessment of hepatic steatosis with histologic correlation. J Am Coll Surg 2008, 206:480-488.
18. Bahl M., Qayyum A., Westphalen A.C., et al. Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. Radiology 2008, 249:160-166.
19. Bohte A.E., van Werven J.R., Bipat S., et al. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol 2011, 21:87-97.
20. Kodama Y., Ng C.S., Wu T.T., et al. Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol 2007, 188:1307-1312.
21. McCormack L., Clavien P.A. Understanding the meaning of fat in the liver. Liver Transpl 2005, 11:137-139.
22. Cho J.Y., Suh K.S., Kwon C.H., et al. The hepatic regeneration power of mild steatotic grafts is not impaired in living-donor liver transplantation. Liver Transpl 2005, 11:210-217.
23. Baccarani U., Adani G.L., Isola M., et al. Steatosis of the graft is a risk factor for posttransplantation biliary complications. Transplant Proc 2009, 41:1313-1315.
24. Guiu Bw, Loffroy R., Ben Salem D., et al. Liver steatosis and in-phase/opposed-phase MR imaging: theory and clinical applications at 3T. J Rad 2007, 88:1845-1853.
25. Marsman W.A., Wiesner R.H., Rodriguez L., et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996, 62:1246-1251.
26. McCormack L., Petrowsky H., Jochum W., et al. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg 2007, 245:923-930.
27. Iwasaki M., Takada Y., Hayashi M., et al. Noninvasive evaluation of graft steatosis in living donor liver transplantation. Transplantation 2004, 78:1501-1505.
28. Lee S.W., Park S.H., Kim K.W., et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 2007, 244:479-485.
29. Szczepaniak L.S., Babcock E.E., Schick F., et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation invivo. Am J Physiol 1999, 276:977-989.
30. Szczepaniak L.S., Nurenberg P., Leonard D., et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005, 288:462-468.
31. Guiu B., Petit J.M., Loffroy R., et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and invivo proton MR spectroscopy. Radiology 2009, 250:95-102.
32. Cassidy F.H., Yokoo T., Aganovic L., et al. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 2009, 29:231-260.